United States: FDA Announces Availability Of Decision Tool And SPL Xforms For MoCRA Facility Registration And Product Listings - Crowell & Moring LLP

Mondaq

17 Jan 2024 0 shares 1 views

United States: FDA Announces Availability Of Decision Tool And SPL Xforms For MoCRA Facility Registration And Product Listings - Crowell & Moring LLP

Mondaq

Published 17 Jan 2024

On January 8, 2024, the U.S. Food and Drug Administration (FDA) announced that SPL Xforms, a Structured Product Labeling authoring tool, is now available as an additional...

Full Article

United States: FDA Launches Cosmetics Direct And Issues Final Guidance On Facility Registration & Product Listings Required Under MoCRA - Crowell & Moring LLP

Mondaq 25 Jan 2024

On December 18, 2023, the U.S. Food and Drug Administration (FDA) launched Cosmetics Direct, the electronic submission portal for..

United States: GAO Report Concludes That The FDA Needs To Strengthen Its Efforts To Implement MoCRA - Crowell & Moring LLP
Mondaq 24 Jan 2024
United States: FDA Delays Enforcement Of MoCRA Facility Registration And Product Listing Requirements - Crowell & Moring LLP
Mondaq 19 Jan 2024

United States: FDA Announces Availability Of Decision Tool And SPL Xforms For MoCRA Facility Registration And Product Listings - Crowell & Moring LLP

United States: FDA Announces Availability Of Decision Tool And SPL Xforms For MoCRA Facility Registration And Product Listings - Crowell & Moring LLP

You might like

Related news coverage

United States: FDA Launches Cosmetics Direct And Issues Final Guidance On Facility Registration & Product Listings Required Under MoCRA - Crowell & Moring LLP

Advertisement